CinCor Pharma, Inc. today announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor.
Menu
CinCor Pharma, Inc. today announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor.
CinRx Pharma announced today that Gavin Samuels, M.D., M.B.A has assumed the role of Chief Business Officer.
CinRx Pharma announced the first study participant has been dosed in CinFina’s Phase 1 multiple ascending dose (MAD) study of CIN-109.
